Successful use of one dose of recombinant factor VIIa to control severe bleeding after emergency aortic arch replacement in deep hypothermic circulatory arrest.
Wiesenack
Christoph
C
Department of Anesthesiology, University Hospital of Regensburg, Franz-Josef-Strauss Allee 11, 93052 Regensburg, Germany. christoph.wiesenack@klinik.uni-regensburg.de
Arlt
Matthias
M
Liebold
Andreas
A
Schmid
Franz X
FX
D000784:Aortic Dissection / Q000601:surgery*; D001014:Aortic Aneurysm / Q000601:surgery*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D019917:Blood Vessel Prosthesis Implantation; D004632:Emergency Medical Services; D005169:Factor VIII / Q000627:therapeutic use*; D006324:Heart Arrest, Induced; D006801:Humans; D007036:Hypothermia, Induced; D008297:Male; D008875:Middle Aged
C078147:F8 protein, human; D005169:Factor VIII